Wang Lulu, Tang Chao, Cheng Mengqiu, Hao Yanhui, Chen Siyue, Zhang Siwei, Zhang Chen, Mol Ben W, Wu Yanting, Huang Hefeng
Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Shanghai, China.
PLoS Med. 2025 Sep 23;22(9):e1004722. doi: 10.1371/journal.pmed.1004722. eCollection 2025 Sep.
It is unknown whether fasting plasma glucose (FPG) level within the normal range as defined by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria is associated with perinatal outcomes. This study explored the associations between FPG levels lower than the IADPSG threshold during oral glucose tolerance test (OGTT) and adverse perinatal outcomes in women with or without gestational diabetes mellitus (GDM).
From January 1, 2017, to May 31, 2022, this single-center retrospective cohort study included 33,417 women with singleton pregnancies at the Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. All women underwent a 75-g OGTT at 24-28 gestational weeks. The primary endpoint was a composite of adverse outcomes, including gestational hypertension, preeclampsia, fetal death and stillbirth, preterm birth, primary cesarean delivery, and small or large for gestational age. Overall, 3,108 (9.5%) women had IADPSG-defined GDM and of whom 2,426 (76.3%) had FPG levels below the IADPSG threshold. Compared to the GDM population, non-GDM women with borderline-normal FPG levels were at significantly greater risk of adverse outcomes with an adjusted odds ratio (aOR) of 1.62 (95% CI [1.20, 2.19]; p = 0.002) at 4.6 mmol/L, an aOR of 1.50 (95% CI [1.05, 2.13]; p = 0.025) at 4.8 mmol/L, and an aOR of 1.58 (95% CI [1.05, 2.40]; p = 0.030) at 4.9 mmol/L glucose level. Nonetheless, non-GDM women demonstrated significantly lower risk (aOR 0.66, 95% CI [0.44, 0.98]; p = 0.038) compared to GDM counterparts exhibiting low fasting glycemia at 3.9 mmol/L. However, this study was limited by its retrospective design and may lack generalizability to other ethnic groups.
Even at FPG levels lower than the IADPSG threshold, FPG was significantly associated with adverse perinatal outcomes, and the associations presented different patterns in women with and without GDM.
国际糖尿病与妊娠研究组(IADPSG)标准所定义的正常范围内的空腹血糖(FPG)水平是否与围产期结局相关尚不清楚。本研究探讨了口服葡萄糖耐量试验(OGTT)期间FPG水平低于IADPSG阈值与患有或未患有妊娠期糖尿病(GDM)的女性不良围产期结局之间的关联。
2017年1月1日至2022年5月31日,这项单中心回顾性队列研究纳入了中国上海复旦大学附属妇产科医院的33417名单胎妊娠女性。所有女性在孕24 - 28周时接受了75克OGTT。主要终点是不良结局的复合指标,包括妊娠期高血压、先兆子痫、胎儿死亡和死产、早产、初次剖宫产以及小于或大于胎龄。总体而言,3108名(9.5%)女性患有IADPSG定义的GDM,其中2426名(76.3%)的FPG水平低于IADPSG阈值。与GDM人群相比,FPG水平临界正常的非GDM女性发生不良结局的风险显著更高,血糖水平为4.6 mmol/L时调整后的优势比(aOR)为1.62(95%CI[1.20, 2.19];p = 0.002),4.8 mmol/L时aOR为1.50(95%CI[1.05, 2.13];p = 0.025),4.9 mmol/L时aOR为1.58(95%CI[1.05, 2.40];p = 0.030)。然而,与空腹血糖水平为3.9 mmol/L的GDM女性相比,非GDM女性的风险显著更低(aOR 0.66,95%CI[0.44, 0.98];p = 0.038)。然而,本研究受其回顾性设计的限制,可能缺乏对其他种族群体的普遍性。
即使FPG水平低于IADPSG阈值,FPG仍与不良围产期结局显著相关,并且这种关联在患有和未患有GDM的女性中呈现出不同的模式。